Cargando…

Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome

CONTEXT: Anti-Müllerian hormone (AMH) measured in adolescence as biomarker for prediction of adult polycystic ovary syndrome (PCOS) is doubtful but not substantiated. OBJECTIVE: To investigate whether serum AMH levels and other PCOS-associated features in adolescence can predict the presence of PCOS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caanen, Mirte R, Peters, Henrike E, van de Ven, Peter M, Jüttner, Anne M F M, Laven, Joop S E, van Hooff, Marcel H A, Lambalk, Cornelis B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947839/ https://www.ncbi.nlm.nih.gov/pubmed/33351079 http://dx.doi.org/10.1210/clinem/dgaa949

Ejemplares similares

Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS)
por: Laven, Joop S. E.
Publicado: (2019)

The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome
por: Meun, Cindy, et al.
Publicado: (2019)

Müllerian Duct Anomalies and Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome
por: Yang, Min, et al.
Publicado: (2023)

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
por: Dewailly, Didier, et al.
Publicado: (2020)

Characteristics of polycystic ovary syndrome throughout life
por: Louwers, Yvonne V., et al.
Publicado: (2020)

Assessment of Anti-Müllerian Hormone Level in Management of Adolescents with Polycystic Ovary Syndrome
por: Dursun, Fatma, et al.
Publicado: (2016)

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
por: Ran, Yu, et al.
Publicado: (2021)

Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
por: di Clemente, Nathalie, et al.
Publicado: (2022)

The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
por: Sivanandy, Mala S., et al.
Publicado: (2023)

Presence of anti-Müllerian hormone (AMH) during follicular development in the porcine ovary
por: Almeida, Fernanda R. C. L., et al.
Publicado: (2018)

Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels
por: Serin, Aliye Nigar, et al.
Publicado: (2021)

Bone morphogenetic proteins and the polycystic ovary syndrome
por: van Houten, E Leonie AF, et al.
Publicado: (2013)

Longitudinal Anti-Müllerian Hormone in Women with Polycystic Ovary Syndrome: An Acupuncture Randomized Clinical Trial
por: Franasiak, Jason, et al.
Publicado: (2012)

Letter to the Editor: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome
por: Joob, Beuy, et al.
Publicado: (2013)

The Author Response: Serum anti-Müllerian hormone levels and phenotypes of polycystic ovary syndrome
por: Kim, Hye Ok
Publicado: (2013)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Anti-Müllerian hormone as a predictor of polycystic ovary syndrome treated with clomiphene citrate
por: Hestiantoro, Andon, et al.
Publicado: (2016)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women
por: Yue, Chao-Yan, et al.
Publicado: (2018)

Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms
por: Ahmed, Nada, et al.
Publicado: (2019)

Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone
por: Mimouni, Nour El Houda, et al.
Publicado: (2021)

Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value
por: Song, Do Kyeong, et al.
Publicado: (2017)

Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS
por: Jiskoot, Geranne, et al.
Publicado: (2023)

Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review
por: Dumont, Agathe, et al.
Publicado: (2015)

Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood
por: Tata, Brooke, et al.
Publicado: (2018)

Androgen and Anti-Mullerian Hormone Concentrations at Term in Newborns and Their Mothers with and without Polycystic Ovary Syndrome
por: Kollmann, Martina, et al.
Publicado: (2019)

Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome
por: Du, Juan, et al.
Publicado: (2021)

The relationship between Anti-Müllerian hormone and other reproductive parameters in normal women and in women with polycystic ovary syndrome
por: Koutlaki, N, et al.
Publicado: (2013)

Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome
por: Moolhuijsen, Loes M E, et al.
Publicado: (2022)

Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
por: Falbo, Angela, et al.
Publicado: (2010)

Circulating anti-mullerian hormone as predictor of ovarian response to clomiphene citrate in women with polycystic ovary syndrome
por: Xi, Wenyan, et al.
Publicado: (2016)

Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome
por: Szafarowska, Monika, et al.
Publicado: (2019)

Anti-Műllerian hormone – a prognostic marker for metformin therapy efficiency in the treatment of women with infertility and polycystic ovary syndrome
por: Neagu, M, et al.
Publicado: (2012)

Assessment of the Role of the Anti-Mullerian Hormone, Luteinizing Hormone/Follicle Stimulating Hormone Ratio in the Diagnosis of Polycystic Ovary Syndrome in Sudanese Women
por: Tola, Hafza, et al.
Publicado: (2018)

Anti-Mullerian Hormone-Based Phenotyping Identifies Subgroups of Women with Polycystic Ovary Syndrome with Differing Clinical and Biochemical Characteristics
por: Nguyen, Minhthao Thi, et al.
Publicado: (2023)

Decline of ovarian function in patients with rheumatoid arthritis: serum anti-Müllerian hormone levels in a longitudinal cohort
por: Brouwer, Jenny, et al.
Publicado: (2020)

Sexual Function in Women With Polycystic Ovary Syndrome: Design of an Observational Prospective Multicenter Case Control Study
por: Pastoor, Hester, et al.
Publicado: (2020)

Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress
por: Singh, Awadhesh Kumar, et al.
Publicado: (2015)

Application of serum anti-Müllerian hormone levels in selecting patients with polycystic ovary syndrome for in vitro maturation treatment
por: Seok, Hyun Ha, et al.
Publicado: (2016)

Is anti-Mullerian hormone a good diagnostic marker for adolescent and young adult patients with Polycystic ovary syndrome?
por: Tokmak, Aytekin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_up7jt0k0s73gp7p5hbdrd2b0dq